acetylcysteine has been researched along with Blood Pressure, High in 53 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (3.77) | 18.7374 |
1990's | 5 (9.43) | 18.2507 |
2000's | 31 (58.49) | 29.6817 |
2010's | 14 (26.42) | 24.3611 |
2020's | 1 (1.89) | 2.80 |
Authors | Studies |
---|---|
Chukhliaev, PV; Garbuzov, AA; Khavkina, DA; Ploskireva, AA; Ruzhentsova, TA | 1 |
Adamcova, M; Aziriova, S; Balazova, L; Celec, P; Krajcirovicova, K; Pechanova, O; Repova, K; Simko, F; Tothova, L; Vrankova, S; Zorad, S | 1 |
Fan, NC; Hsu, CN; Huang, LT; Tain, YL; Tsai, CM | 1 |
Carbajosa, NA; Congo Carbajosa, NA; Corradi, G; Gironacci, MM; Guil, MJ; Vatta, MS; Verrilli, MA | 1 |
Dasgupta, C; Huang, X; Li, Y; Wang, L; Xiao, D; Zhang, L | 1 |
Bonaterra, G; Dugi, KA; Edler, L; Hildebrandt, W; Kinscherf, R; Sauer, R | 1 |
Chen, CC; Huang, LT; Lin, YJ; Sheen, JM; Tai, IH; Tain, YL; Tiao, MM; Yu, HR | 1 |
Hsu, CN; Lee, CT; Lin, YJ; Tain, YL; Tsai, CC | 1 |
Chan, JY; Hsu, CN; Lee, CT; Tain, YL | 1 |
Couture, R; de Champlain, J; El Midaoui, A; Fantus, IG; Ismael, MA; Lu, H | 1 |
Dominiczak, AF; Fields, L; Graham, D; Hamilton, CA; Koh-Tan, HH; McBride, MW; Nicoll, G; Young, B | 1 |
Gadag, V; Gill, VD; Han, Y; Randell, E; Vasdev, S | 1 |
Albini, A; Cammarota, R; De Flora, S; Donatelli, F; Noonan, DM; Pennesi, G | 1 |
Dobesova, Z; Kunes, J; Pechanova, O; Vrankova, S; Zicha, J | 1 |
Barta, A; Janega, P; Parohova, J; Pechanova, O; Simko, F; Vrankova, S | 1 |
He, RX; Hu, CP; Luo, YQ; Su, XL; Xiang, YH | 1 |
Anand-Srivastava, MB; Li, Y; Sandoval, YH | 1 |
Ieiri, I; Iwase, M; Kitazono, T; Matsuyama, N; Ohdo, S; Sonoki, K; Takata, Y | 1 |
de Oliveira, MG; Krieger, MH; Ricardo, KF; Shishido, SM | 1 |
Barrios, V; Calderón, A; Lahera, V; Navarro-Cid, J; Ruilope, LM | 1 |
Chulak, C; de Champlain, J; Girouard, H; Lamontagne, D; LeJossec, M | 1 |
Chulak, C; de Champlain, J; Girouard, H; Lejossec, M; Wu, L | 1 |
Adamy, C; Adubeiro, S; Badoual, T; Bourin, MC; Bourraindeloup, M; Cailleret, M; Candiani, G; Dubois-Rande, JL; Hittinger, L; Pecker, F; Roudot-Thoraval, F; Su, JB | 1 |
Chulak, C; de Champlain, J; Denault, C; Girouard, H | 1 |
Fujii, S; Igarashi, J; Kosaka, H; Zhang, L | 1 |
Hutchings, S; Pang, CC; Song, D | 1 |
Delles, C; John, S; Oehmer, S; Schmidt, BM; Schmieder, RE; Schneider, MP; Schwarz, TK | 1 |
Dobesová, Z; Kunes, J; Pechánová, O; Rauchová, H; Vokurková, M; Zicha, J | 1 |
Barbosa, E; Chang, EY; Paintlia, MK; Singh, A; Singh, I | 1 |
Dobesová, Z; Jendeková, L; Kojsová, S; Kunes, J; Pechánová, O; Zicha, J | 1 |
Anand-Srivastava, MB; Daou, GB; Lappas, G | 1 |
Barrett, BJ; Parfrey, PS | 1 |
de Macedo Possamai, V; Guo, Z; Hu, L; McKenzie, KU; Miao, Y; Mondo, CK; Schyvens, CG; Whitworth, JA; Zhang, Y | 1 |
Dwyer, TM; Hughson, MD; Jordan, S; Manning, RD; Rose, RA; Tian, N | 1 |
Thaha, M; Tomino, Y; Yogiantoro, M | 1 |
Dobesová, Z; Dovinová, I; Jendeková, L; Kojsová, S; Kunes, J; Paulis, L; Pechánová, O; Simko, F; Sládková, M; Zenebe, W; Zicha, J | 1 |
Biswas, SK; de Faria, JB | 1 |
Dobesová, Z; Kunes, J; Zicha, J | 1 |
Chhabra, P; Doctor, A; Forbes, MS; Gaston, B; Karlinsey, MZ; Laubach, VE; Macdonald, T; Palmer, LA; Sheram, ML | 1 |
Macarthur, H; Westfall, TC; Wilken, GH | 1 |
de Souza, HP; dos Santos, L; Garcia, JA; Krieger, MH; Moura, AL; Ricardo, KF; Shishido, SM; Spadari-Bratfisch, RC; Wanschel, AC | 1 |
Berchio, A; Bergamini, S; Brocato, L; Della Casa, L; Gigliardi, VR; Iannone, A; Manzato, E; Martina, V; Masha, A; Massarenti, P; Settanni, F | 1 |
Croft, KD; Krug, S; Langton, LK; Mori, TA; Vickers, JJ; Whitworth, JA; Zhang, Y | 1 |
del Arco, C; Lahera, V; Ruilope, LM; Suárez, C | 1 |
Carbonell, LF; Inglés, AC; Quesada, T; Ruiz, FJ; Salom, MG; Vicente, E | 1 |
Longerich, L; Mian, T; Parai, S; Prabhakaran, V; Vasdev, S | 1 |
Ford, CA; Gadag, V; Longerich, L; Vasdev, S; Wadhawan, S | 1 |
Besner, JG; Bouchard, JF; Cabassi, A; de Champlain, J; Dumont, EC; Girouard, H; Lamontagne, D; Le Jossec, M | 2 |
Chun, TH; Doi, K; Fukunaga, Y; Inoue, M; Itoh, H; Masatsugu, K; Mori, Y; Nakao, K; Ogawa, Y; Saito, T; Sawada, N; Tanaka, T; Yamahara, K; Yamashita, J | 1 |
Ford, CA; Gadag, V; Longerich, L; Parai, S; Vasdev, S; Wadhawan, S | 1 |
Bodemann, T; Hochrein, H; Langescheid, C | 1 |
Blumstein, CG | 1 |
3 review(s) available for acetylcysteine and Blood Pressure, High
Article | Year |
---|---|
Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention.
Topics: Acetylcysteine; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Animals; Anti-Inflammatory Agents, Non-Steroidal; Anticoagulants; Antineoplastic Agents; Atrial Fibrillation; Blood Coagulation; Cardiotonic Agents; Cardiovascular Diseases; Cardiovascular System; Flavonoids; Free Radical Scavengers; Heart; Humans; Hypertension; Patient Care Team; Phenols; Platelet Aggregation Inhibitors; Polyphenols; Stroke Volume; Venous Thromboembolism; Ventricular Dysfunction, Left | 2010 |
Clinical practice. Preventing nephropathy induced by contrast medium.
Topics: Acetylcysteine; Aged; Contrast Media; Coronary Angiography; Diabetes Mellitus, Type 2; Fluid Therapy; Humans; Hypertension; Kidney Diseases; Male; Practice Guidelines as Topic; Risk Factors | 2006 |
Drug treatment in bronchial asthma.
Topics: Acetylcysteine; Anti-Bacterial Agents; Asthma; Bronchodilator Agents; Caffeine; Drug Combinations; Ephedrine; Epinephrine; Expectorants; Glucocorticoids; Guaifenesin; Humans; Hypertension; Isoproterenol; Mucus; Sympathomimetics; Theophylline; Xanthines | 1973 |
6 trial(s) available for acetylcysteine and Blood Pressure, High
Article | Year |
---|---|
Oral N-acetylcysteine reduces plasma homocysteine concentrations regardless of lipid or smoking status.
Topics: Acetylcysteine; Administration, Oral; Adult; Antihypertensive Agents; Antioxidants; Biotransformation; Cholesterol; Cysteine; Double-Blind Method; Glutathione; Homocysteine; Humans; Hyperhomocysteinemia; Hyperlipidemias; Hypertension; Leukocytes, Mononuclear; Male; Middle Aged; Smoking; Triglycerides | 2015 |
Telmisartan and N-acetylcysteine suppress group V secretory phospholipase A2 expression in TNFα-stimulated human endothelial cells and reduce associated atherogenicity.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Antioxidants; Atherosclerosis; Benzimidazoles; Benzoates; Chemokine CCL2; Diabetes Mellitus, Type 2; Female; Gene Expression Regulation; Group V Phospholipases A2; Human Umbilical Vein Endothelial Cells; Humans; Hypertension; Lipoproteins, LDL; Lysophosphatidylcholines; Male; Middle Aged; RNA, Messenger; Telmisartan; Tumor Necrosis Factor-alpha | 2012 |
N-acetylcysteine potentiates the antihypertensive effect of ACE inhibitors in hypertensive patients.
Topics: Acetylcysteine; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Blood Pressure; Blood Pressure Monitoring, Ambulatory; Circadian Rhythm; Cross-Over Studies; Drug Synergism; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Smoking | 2002 |
Superoxide scavenging effects of N-acetylcysteine and vitamin C in subjects with essential hypertension.
Topics: Acetylcholine; Acetylcysteine; Adult; Ascorbic Acid; Blood Flow Velocity; Endothelium, Vascular; Female; Forearm; Free Radical Scavengers; Humans; Hypertension; Infusions, Intra-Arterial; Male; Middle Aged; Nitroprusside; Superoxides; Vasodilation; Vasodilator Agents | 2005 |
Intravenous N-acetylcysteine during haemodialysis reduces the plasma concentration of homocysteine in patients with end-stage renal disease.
Topics: Acetylcysteine; Adult; Aged; Blood Pressure; Blood Proteins; Diabetic Nephropathies; Drug Administration Schedule; Female; Heart Rate; Hematocrit; Homocysteine; Humans; Hypertension; Infusions, Intravenous; Kidney Calculi; Kidney Failure, Chronic; Male; Middle Aged; Renal Dialysis; Treatment Outcome; Urticaria | 2006 |
Long-term N-acetylcysteine and L-arginine administration reduces endothelial activation and systolic blood pressure in hypertensive patients with type 2 diabetes.
Topics: Acetylcysteine; Administration, Oral; Aged; Arginine; Blood Pressure; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Endothelium, Vascular; Humans; Hypertension; Hypoglycemic Agents; Male; Middle Aged; Placebos; Systole | 2008 |
44 other study(ies) available for acetylcysteine and Blood Pressure, High
Article | Year |
---|---|
[Effect of anticoagulant therapy on the course of COVID-19 in comorbid patients].
Topics: Acetylcysteine; Aged; Aged, 80 and over; Anticoagulants; Antiviral Agents; Atrial Fibrillation; Azithromycin; Cohort Studies; Comorbidity; Coronary Disease; COVID-19; COVID-19 Drug Treatment; Dabigatran; Disseminated Intravascular Coagulation; Female; Humans; Hypertension; Indoles; Interferon alpha-2; Intracranial Arteriosclerosis; Male; Middle Aged; Pyrazoles; Pyridones; Rivaroxaban; SARS-CoV-2; Severity of Illness Index; Survival Analysis | 2021 |
Lactacystin-Induced Model of Hypertension in Rats: Effects of Melatonin and Captopril.
Topics: Acetylcysteine; Animals; Antihypertensive Agents; Captopril; Disease Models, Animal; Fibrosis; Heart Ventricles; Hypertension; Light; Male; Melatonin; NG-Nitroarginine Methyl Ester; Rats; Rats, Wistar; Ventricular Remodeling | 2017 |
N-acetylcysteine prevents hypertension via regulation of the ADMA-DDAH pathway in young spontaneously hypertensive rats.
Topics: Acetylcysteine; Amidohydrolases; Animals; Arginine; Blood Pressure; Glutathione; Humans; Hypertension; Metabolic Networks and Pathways; Nitric Oxide; Oxidative Stress; Rats; Superoxides | 2013 |
Tyrosine hydroxylase is short-term regulated by the ubiquitin-proteasome system in PC12 cells and hypothalamic and brainstem neurons from spontaneously hypertensive rats: possible implications in hypertension.
Topics: Acetylcysteine; Animals; Brain Stem; Hypertension; Hypothalamus; Male; Neurons; PC12 Cells; Proteasome Endopeptidase Complex; Proteasome Inhibitors; Rats; Rats, Inbred SHR; Rats, Wistar; Tyrosine 3-Monooxygenase; Ubiquitin | 2015 |
Antenatal Antioxidant Prevents Nicotine-Mediated Hypertensive Response in Rat Adult Offspring.
Topics: Acetylcysteine; Angiotensin II; Animals; Antioxidants; Body Weight; Enzyme Activation; Female; Humans; Hypertension; Muscle Relaxation; Muscle, Smooth, Vascular; Nicotine; Nicotinic Agonists; Phorbol 12,13-Dibutyrate; Pregnancy; Prenatal Exposure Delayed Effects; Protein Kinase C; Rats; Rats, Sprague-Dawley; Reactive Oxygen Species | 2015 |
Maternal N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and prevents programmed hypertension in male offspring exposed to prenatal dexamethasone and postnatal high-fat diet.
Topics: Acetylcysteine; Animals; Dexamethasone; Diet, High-Fat; Female; Hydrogen Sulfide; Hypertension; Male; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley | 2016 |
N-Acetylcysteine Prevents Programmed Hypertension in Male Rat Offspring Born to Suramin-Treated Mothers.
Topics: Acetylcysteine; Animals; Arginine; Blood Pressure; Female; Fetal Development; Hydrogen Sulfide; Hypertension; Kidney; Male; Nitric Oxide; Pre-Eclampsia; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Suramin | 2016 |
Maternal melatonin or N-acetylcysteine therapy regulates hydrogen sulfide-generating pathway and renal transcriptome to prevent prenatal N
Topics: Acetylcysteine; Administration, Oral; Animals; Antioxidants; Biomarkers; Female; Fetal Development; Hydrogen Sulfide; Hypertension; Kidney; Male; Melatonin; NG-Nitroarginine Methyl Ester; Oxidative Stress; Pregnancy; Prenatal Exposure Delayed Effects; Rats; Rats, Sprague-Dawley; Transcriptome | 2016 |
Comparative effects of N-acetyl-L-cysteine and ramipril on arterial hypertension, insulin resistance, and oxidative stress in chronically glucose-fed rats.
Topics: Acetylcysteine; Aldehydes; Angiotensin-Converting Enzyme Inhibitors; Animals; Aorta, Thoracic; Blood Pressure; Diet; Free Radical Scavengers; Glucose; Hypertension; Insulin Receptor Substrate Proteins; Insulin Resistance; Lipid Peroxidation; Liver; Male; Malondialdehyde; Muscle, Skeletal; NADPH Oxidases; Oxidative Stress; Oxygen Consumption; Ramipril; Rats; Rats, Wistar | 2008 |
Renal and vascular glutathione S-transferase mu is not affected by pharmacological intervention to reduce systolic blood pressure.
Topics: Acetylcysteine; Animals; Glutathione Transferase; Humans; Hydrochlorothiazide; Hypertension; Imidazoles; Kidney; Male; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxides; Systole; Tetrazoles | 2009 |
Fructose and moderately high dietary salt-induced hypertension: prevention by a combination of N-acetylcysteine and L-arginine.
Topics: Acetylcysteine; Animals; Antihypertensive Agents; Arginine; Blood Pressure; Body Weight; Dose-Response Relationship, Drug; Drug Combinations; Drug Evaluation, Preclinical; Fructose; Heart; Hypertension; Kidney; Liver; Myocardium; Organ Size; Rats; Rats, Inbred WKY; Sodium Chloride, Dietary | 2010 |
Contribution of neuronal nitric oxide (no) synthase to N-acetylcysteine-induced increase of NO synthase activity in the brain of normotensive and hypertensive rats.
Topics: Acetylcysteine; Animals; Blood Pressure; Body Weight; Brain; Brain Stem; Cerebellum; Dose-Response Relationship, Drug; Free Radical Scavengers; Heart; Hypertension; Male; Nitric Oxide Synthase; Nitric Oxide Synthase Type I; Organ Size; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Species Specificity | 2009 |
Effect of nuclear factor kappa B inhibition on L-NAME-induced hypertension and cardiovascular remodelling.
Topics: Acetylcysteine; Animals; Blood Pressure; Hypertension; Male; NF-kappa B; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Inbred WKY; Ventricular Remodeling | 2010 |
[A study of the related pathways of oxidative stress in chronic intermittent hypoxia rats and the effect of N-acetylcysteine].
Topics: Acetylcysteine; Animals; Antioxidants; Blood Pressure; Hypertension; Hypoxia; Male; Oxidative Stress; Rats; Rats, Sprague-Dawley; Renin-Angiotensin System; Sleep Apnea, Obstructive | 2010 |
Transactivation of epidermal growth factor receptor by enhanced levels of endogenous angiotensin II contributes to the overexpression of Giα proteins in vascular smooth muscle cells from SHR.
Topics: Acetylcysteine; Adenylyl Cyclases; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Colforsin; CSK Tyrosine-Protein Kinase; ErbB Receptors; Gene Expression; GTP-Binding Protein alpha Subunits, Gi-Go; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hypertension; Mitogen-Activated Protein Kinases; Muscle, Smooth, Vascular; Myocytes, Smooth Muscle; Oxidative Stress; Phosphorylation; Protein-Tyrosine Kinases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; src-Family Kinases; Transcriptional Activation | 2011 |
Characterization of the hypotensive effect of S-nitroso-N-acetylcysteine in normotensive and hypertensive conscious rats.
Topics: Acetylcysteine; Animals; Blood Pressure; Cyclic GMP; Dose-Response Relationship, Drug; Drug Stability; Drug Synergism; Drug Therapy, Combination; Hypertension; Male; Rats; Rats, Wistar; Sulfhydryl Compounds; Vasodilation | 2002 |
Chronic antioxidant treatment improves sympathetic functions and beta-adrenergic pathway in the spontaneously hypertensive rats.
Topics: Acetylcysteine; Adenylyl Cyclases; Adrenergic beta-Agonists; Animals; Antioxidants; Aorta; Binding Sites; Binding, Competitive; Blood Pressure; Catecholamines; Drug Administration Schedule; Heart Rate; Hypertension; In Vitro Techniques; Isoproterenol; Male; Melatonin; Mesenteric Arteries; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta; Sympathetic Nervous System | 2003 |
N-acetylcysteine improves nitric oxide and alpha-adrenergic pathways in mesenteric beds of spontaneously hypertensive rats.
Topics: Acetylcysteine; Adrenergic Fibers; Animals; Hemodynamics; Hypertension; Mesenteric Arteries; Nitric Oxide; Rats; Splanchnic Circulation | 2003 |
N-acetylcysteine treatment normalizes serum tumor necrosis factor-alpha level and hinders the progression of cardiac injury in hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Collagen; Disease Progression; Drug Evaluation, Preclinical; Glutathione; Heart Ventricles; Hypertension; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Myocardial Contraction; Myocardium; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Oxidative Stress; Rats; Rats, Wistar; Sodium Chloride, Dietary; Sphingomyelin Phosphodiesterase; Tumor Necrosis Factor-alpha; Ultrasonography; Ventricular Dysfunction, Left; Ventricular Remodeling | 2004 |
Treatment by n-acetylcysteine and melatonin increases cardiac baroreflex and improves antioxidant reserve.
Topics: Acetylcysteine; Animals; Antioxidants; Baroreflex; Blood Pressure; Catecholamines; Erythrocytes; Glutathione Peroxidase; Heart; Heart Rate; Hypertension; Hypertrophy, Left Ventricular; Male; Melatonin; Organ Size; Oxidoreductases; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Superoxide Dismutase | 2004 |
Effects of thiol antioxidant on reduced nicotinamide adenine dinucleotide phosphate oxidase in hypertensive Dahl salt-sensitive rats.
Topics: Acetylcholine; Acetylcysteine; Animals; Antioxidants; Blood Pressure; Dinoprost; Endothelium, Vascular; Hydrogen Peroxide; Hypertension; Kidney Glomerulus; Male; NADPH Oxidases; Oxidative Stress; Proteinuria; Rats; Rats, Inbred Dahl; Sodium Chloride; Superoxides; Thromboxane B2; Up-Regulation | 2004 |
Chronic N-acetylcysteine prevents fructose-induced insulin resistance and hypertension in rats.
Topics: Acetylcysteine; Adrenergic alpha-Agonists; Animals; Blood Pressure; Dinoprost; Dose-Response Relationship, Drug; Fructose; Glucose Tolerance Test; Hypertension; Insulin Resistance; Male; Methoxamine; Random Allocation; Rats; Rats, Sprague-Dawley; Triglycerides | 2005 |
Chronic N-acetylcysteine administration prevents development of hypertension in N(omega)-nitro-L-arginine methyl ester-treated rats: the role of reactive oxygen species.
Topics: Acetylcysteine; Animals; Antioxidants; Aorta; Cyclic N-Oxides; Drug Interactions; Enzyme Inhibitors; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide Synthase; Rats; Rats, Wistar; Reactive Oxygen Species; Spin Labels | 2005 |
The use of N-acetylcysteine for the prevention of hypertension in the reduced uterine perfusion pressure model for preeclampsia in Sprague-Dawley rats.
Topics: Acetylcysteine; Animals; Blood Pressure; Disease Models, Animal; Female; Fetal Weight; Hypertension; Pre-Eclampsia; Pregnancy; Rats; Rats, Sprague-Dawley; Uterus | 2005 |
Effect of chronic N-acetylcysteine treatment on the development of spontaneous hypertension.
Topics: Acetylcysteine; Aging; Animals; Antioxidants; Glutathione; Heart Ventricles; Hypertension; Kidney; Male; NF-kappa B; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Random Allocation; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species | 2006 |
Oxidative stress contributes to the enhanced expression of Gialpha proteins and adenylyl cyclase signaling in vascular smooth muscle cells from spontaneously hypertensive rats.
Topics: Acetylcysteine; Adenylyl Cyclases; Animals; Antioxidants; Cells, Cultured; Colforsin; Flavonoids; GTP-Binding Protein alpha Subunits, Gi-Go; GTP-Binding Protein alpha Subunits, Gs; Guanosine 5'-O-(3-Thiotriphosphate); Hypertension; Isoproterenol; MAP Kinase Signaling System; Models, Biological; Muscle, Smooth, Vascular; Onium Compounds; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Signal Transduction; Superoxides | 2005 |
N-acetylcysteine antagonizes the development but does not reverse ACTH-induced hypertension in the rat.
Topics: Acetylcysteine; Adrenocorticotropic Hormone; Animals; Blood Pressure; Disease Models, Animal; Free Radical Scavengers; Hypertension; Male; Rats; Rats, Sprague-Dawley; Treatment Outcome | 2006 |
N-Acetylcysteine improves renal dysfunction, ameliorates kidney damage and decreases blood pressure in salt-sensitive hypertension.
Topics: Acetylcysteine; Animals; Blood Pressure; Disease Models, Animal; Free Radical Scavengers; Glomerular Filtration Rate; Glutathione; Hypertension; Kidney Diseases; Male; Oxidative Stress; Rats; Rats, Inbred Dahl; Sodium Chloride, Dietary | 2006 |
The effect of N-acetylcysteine and melatonin in adult spontaneously hypertensive rats with established hypertension.
Topics: Acetylcysteine; Alkadienes; Animals; Antioxidants; Blood Pressure; Blotting, Western; Free Radical Scavengers; Hypertension; Male; Melatonin; Myography; NF-kappa B; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Reactive Oxygen Species; Vasoconstriction | 2007 |
Which comes first: renal inflammation or oxidative stress in spontaneously hypertensive rats?
Topics: 8-Hydroxy-2'-Deoxyguanosine; Acetylcysteine; Age Factors; Animals; Antioxidants; Blood Pressure; Cyclic N-Oxides; Deoxyguanosine; Disease Models, Animal; Disease Progression; DNA Damage; Glutathione; Hypertension; Kidney Cortex; Male; NADPH Oxidases; Nephritis; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Spin Labels; Tyrosine | 2007 |
Antihypertensive mechanisms of chronic captopril or N-acetylcysteine treatment in L-NAME hypertensive rats.
Topics: Acetylcysteine; Animals; Antihypertensive Agents; Blood Pressure; Captopril; Hypertension; Male; NG-Nitroarginine Methyl Ester; Nitroprusside; Pentolinium Tartrate; Rats; Rats, Wistar; Tetraethylammonium | 2006 |
S-nitrosothiols signal hypoxia-mimetic vascular pathology.
Topics: Acetylcysteine; Animals; Erythrocytes; Glutathione; Hypertension; Hypoxia; Mice; Mice, Knockout; Nitric Oxide Synthase Type III; Nitro Compounds; Nitroso Compounds; Oxygen; Pulmonary Artery; S-Nitrosothiols; Signal Transduction | 2007 |
Oxidative stress attenuates NO-induced modulation of sympathetic neurotransmission in the mesenteric arterial bed of spontaneously hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Arginine; Blood Pressure; Disease Models, Animal; Electric Stimulation; Enzyme Inhibitors; Hypertension; Male; Mesenteric Arteries; Neuropeptide Y; NG-Nitroarginine Methyl Ester; Nitric Oxide; Nitric Oxide Synthase; Norepinephrine; Oxidative Stress; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Neuropeptide Y; Splanchnic Circulation; Superoxides; Sympathetic Nervous System | 2008 |
S-nitroso-N-acetylcysteine (SNAC) prevents myocardial alterations in hypercholesterolemic LDL receptor knockout mice by antiinflammatory action.
Topics: Acetylcysteine; Animals; Anti-Inflammatory Agents; Blood Pressure; CD40 Ligand; Gene Expression Regulation, Enzymologic; Hypercholesterolemia; Hypertension; Hypertrophy, Left Ventricular; Inflammation; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardial Contraction; Nitric Oxide Synthase Type III; Receptors, LDL | 2008 |
N-Acetylcysteine prevents but does not reverse dexamethasone-induced hypertension.
Topics: Acetylcysteine; Animals; Blood Pressure; Dexamethasone; Energy Metabolism; F2-Isoprostanes; Hypertension; Male; Nitric Oxide; Rats; Rats, Sprague-Dawley | 2008 |
N-acetylcysteine potentiates the antihypertensive effect of angiotensin converting enzyme inhibitors.
Topics: Acetylcysteine; Angiotensin-Converting Enzyme Inhibitors; Drug Therapy, Combination; Humans; Hypertension | 1995 |
N-acetyl-L-cysteine potentiates depressor response to captopril and enalaprilat in SHRs.
Topics: Acetylcysteine; Animals; Blood Pressure; Captopril; Drug Synergism; Enalaprilat; Hypertension; Male; Rats; Rats, Inbred SHR | 1994 |
N-acetyl cysteine attenuates ethanol induced hypertension in rats.
Topics: Acetaldehyde; Acetylcysteine; Administration, Oral; Animals; Aorta; Blood Platelets; Blood Pressure; Body Weight; Calcium; Cytosol; Energy Intake; Ethanol; Heart; Hypertension; Kidney; Lipid Peroxidation; Liver; Male; Muscle, Smooth, Vascular; Myocardium; Organ Size; Rats; Rats, Inbred WKY; Renal Circulation; Thiobarbituric Acid Reactive Substances | 1995 |
Role of aldehydes in fructose induced hypertension.
Topics: Acetylcysteine; Aldehydes; Animals; Blood Platelets; Blood Pressure; Body Weight; Calcium; Diet; Drinking; Eating; Fructose; Hypertension; Kidney; Lipofuscin; Organ Size; Rats; Rats, Inbred WKY | 1998 |
Effect of antioxidant treatments on nitrate tolerance development in normotensive and hypertensive rats.
Topics: Acetylcysteine; Animals; Antioxidants; Coronary Vessels; Drug Tolerance; Endothelium, Vascular; Hypertension; In Vitro Techniques; Lipid Peroxidation; Male; Malondialdehyde; Melatonin; Nitrates; Nitroprusside; Perfusion; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Serotonin; Vasodilation | 2000 |
Oxidative stress augments secretion of endothelium-derived relaxing peptides, C-type natriuretic peptide and adrenomedullin.
Topics: Acetylcysteine; Adrenomedullin; Animals; Antioxidants; Arteriosclerosis; Base Sequence; Cattle; Cells, Cultured; DNA Primers; Endothelium, Vascular; Gene Expression; Humans; Hydrogen Peroxide; Hypertension; Natriuretic Peptide, C-Type; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Oxidative Stress; Peptides; RNA, Messenger; Vasodilation | 2000 |
Aldehyde induced hypertension in rats: prevention by N-acetyl cysteine.
Topics: Acetylcysteine; Aldehydes; Animals; Arterioles; Blood Platelets; Blood Pressure; Body Weight; Calcium; Carbohydrate Metabolism; Diet; Drinking; Eating; Energy Intake; Hyperplasia; Hypertension; Insulin Resistance; Kidney; Male; Muscle, Skeletal; Muscle, Smooth, Vascular; Nitrates; Nitric Oxide; Nitrites; Organ Size; Pyruvaldehyde; Rats; Rats, Inbred WKY; Renal Artery; Viscera | 1998 |
Effects of chronic N-acetylcysteine treatment on the actions of peroxynitrite on aortic vascular reactivity in hypertensive rats.
Topics: Acetylcholine; Acetylcysteine; Animals; Aorta; Drug Synergism; Free Radical Scavengers; Glutathione; Glutathione Disulfide; Hypertension; In Vitro Techniques; Isoproterenol; Male; Malondialdehyde; Nitrates; Nitroprusside; Peroxynitrous Acid; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Time Factors; Tyrosine; Vasodilation; Vasodilator Agents; Vasomotor System | 2001 |
[Nitrate tolerance and its management by N-acetylcysteine (studies of patients with severe chronic heart failure)].
Topics: Acetylcysteine; Cardiomyopathy, Dilated; Coronary Disease; Drug Therapy, Combination; Drug Tolerance; Female; Heart Failure; Hemodynamics; Humans; Hypertension; Infusions, Intravenous; Male; Middle Aged; Nitroglycerin | 1989 |